Factor Bioscience Successfully Defends Three U.S. Patents Covering Foundational Methods For Therapeutic Gene Editing
(MENAFN- PR Newswire) -Patented methods relate to multiple allogeneic CAR T-cell therapies under clinical development for the treatment of B-cell lymphoma, chronic lymphocytic leukemia, multiple myeloma, and renal cell carcinoma -Patented methods also …